NLRP3 and familial dilated cardiomyopathy: So far there are 5 active agents, ginsenoside Rg1, gypenosides, quercetin, ursolicacid, salidroside confirmed to ameliorate DCM through inhibition of NLRP3 inflammasome (Fig 3).